Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...
Zacks Investment Research on MSN
Elekta wins FDA nod for Evo CT-Linac, boosting US radiation oncology
Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system ...
Elekta and its global collaborators overcame significant engineering hurdles to demonstrate the technology’s feasibility. Previously, experts in the field thought it nearly impossible to combine MRI ...
The FINANCIAL — Elekta (EKTA-B.ST), Royal Philips and The Netherlands Cancer Institute, (NKI, Amsterdam, the Netherlands) on April 17 announced the installation of a high-field (1.5 Tesla) MR-guided ...
GUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo ...
In order to deliver Adaptive Radiation Therapy (ART) for cancer, Elekta, a global leader in precision radiation therapy, will launch an advanced AI-enabled CT-Linac (linear accelerator) by the name ...
Aug. 19—LENOIR — McCreary Cancer Center, a service of UNC Hospitals, is expanding in Lenoir. The expansion will add a brand new Elekta Infinity linear accelerator to the city. The Elekta unit delivers ...
ATLANTA - Elekta (EKTA-B.ST) announced that its Elekta Evo* CT-Linac has today received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This milestone makes the system available to ...
HOUSTON--(BUSINESS WIRE)--Regulatory News: The University of Texas MD Anderson Cancer Center has signed a deal with Elekta (EKTA-B.ST) to acquire Elekta Infinity ...
ATLANTA — With much pomp and circumstance, Elekta (Stockholm, Sweden) unveiled its Versa HD, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results